● Recruiting

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Condition: Breast Cancer · Advanced Solid Tumor · Sponsor: BeOne Medicines

PhasePhase 1

Planned participants86

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75202 (KAT6A/B inhibitor) alone and in combination with other therapies in participants with breast cancer and other advanced solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 877-828-5568 · clinicaltrials@beonemed.com

Always discuss trial participation with your own doctor first.

Locations (29)

University of Alabama At Birmingham Hospital	Birmingham, Alabama, United States	Recruiting
Yale Cancer Center	New Haven, Connecticut, United States	Recruiting
Washington University in St Louis	St Louis, Missouri, United States	Recruiting
Next Oncology Austin	Austin, Texas, United States	Recruiting
The University of Texas Md Anderson Cancer Center	Houston, Texas, United States	Recruiting
Fred Hutchinson Cancer Research Center	Seattle, Washington, United States	Recruiting
Blacktown Cancer and Haematology Centre	Blacktown, New South Wales, Australia	Recruiting
Chris Obrien Lifehouse	Camperdown, New South Wales, Australia	Recruiting
Cancer Research South Australia	Adelaide, South Australia, Australia	Recruiting
Austin Health	Heidelberg, Victoria, Australia	Recruiting
Peter Maccallum Cancer Centre	Melbourne, Victoria, Australia	Recruiting
Cancer Hospital Chinese Academy of Medical Sciences	Beijing, Beijing Municipality, China	Recruiting

+ 17 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07222267